GALYNA VOROKHIB: Open Payments
NPI 1508403569 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,502 in 96 payments from 19 companies in 2025. Trend: 2023 $1,920 · 2024 $2,133 · 2025 $3,502
Food & beverage: $2,482Travel & lodging: $1,014Education: $7
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 43 | $2,127 |
| Novo Nordisk Inc | 9 | $284 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $199 |
| Aimmune Therapeutics, Inc. | 6 | $164 |
| E.R. Squibb & Sons, L.L.C. | 1 | $135 |
| Amphastar Pharmaceuticals, Inc. | 5 | $99 |
| Lilly USA, LLC | 4 | $80 |
| SANOFI-AVENTIS U.S. LLC | 2 | $63 |
| BETA BIONICS, INC. | 2 | $54 |
| Insulet Corporation | 2 | $47 |
Products named: MINIMED 780G, JARDIANCE, Ozempic, ZENPEP, CAMZYOS, TZIELD, iLet Bionic Pancreas, Omnipod.
Industry payments across PA — which companies pay providers there.
